The Hemophilic Joints
نویسنده
چکیده
Recurrent hemarthroses in childhhood before the initiation of primary prophylaxis will result in joint damage after a decade or later. The best way that we have today to protecting against hemophilic arthropathy is primary prophylaxis. The decision to institute early full prophylaxis by means of a port (central venous access device) has to be balanced against the child’s bleeding tendency, the family’s social situation and the experience of the specific hemophilia center. The reported complication rates for infection and thrombosis have varied considerably from center to center. Risk of infection can be reduced by repeated education of patients and staff, effective surveillance routines and limitations on the number of individuals allowed to use the device. In discussing options for early therapy, the risks and benefits should be thoroughly discussed with the parents. From a practical point of view, primary prophylaxis together with synovectomy (radioactive, chemical, arthroscopic, or open) to avoid joint bleeding, can help halt hemophilic synovitis. Radiosynovectomy is a relatively simple, virtually painless and inexpensive treatment for chronic hemophilic synovitis, even in patients with inhibitors and must be the best choice for patients with persistent synovitis (which must be confirmed by US and/or MRI). Arthroscopic joint debridement may be indicated in younger hemophiliacs when there is relative preservation of the joint architecture and congruity, after the failure of three radiosynovectomies with a 6-month interval, and when joint replacement is not considered to be a viable alternative. Total joint arthroplasty should be indicated in hemophiliacs with severe joint pain and disability, including those who are HIV-positive. Hemophilia is a risk factor for infection after total joint arthroplasty. An extended period (2-3 weeks) of adequate hemostatic function is necessary to achieve normal healing after orthopedic procedures in hemophilia. unavoidable and is associated with an increased incidence of infections [2,3]. Any preventive measure should be implemented very early, because a relatively short exposure of cartilage to blood may result in longlasting changes in chondrocyte metabolism that may eventually lead to chronic degenerative changes (hemophilic arthropathy). There are three basic invasive methods for the management of the hemophilic joint: synovectomy (radioactive, chemical, arthroscopic or open), arthroscopic joint debridement and joint arthroplasty [4]. Other conservative treatments such as physiotherapy and/or sports therapy as well as other fields of rehabilitation medicine are not focussed in this paper. In other words, this article only deals with orthopaedic treatment options. In this paper current knowledge on the pathogenesis, diagnosis and orthopaedic treatment of the hemophilic joint will be revised.
منابع مشابه
Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.
Hemophilic bleeding into joints causes synovial and microvascular proliferation and inflammation (hemophilic synovitis) that contribute to end-stage joint degeneration (hemophilic arthropathy), the major morbidity of hemophilia. New therapies are needed for joint deterioration that progresses despite standard intravenous (IV) clotting factor replacement. To test whether factor IX within the joi...
متن کاملThe Efficacy of Magnetic Resonance Imaging and X-Ray in the Evaluation of Response to Radiosynovectomy in Patients with Hemophilic Arthropathy
OBJECTIVE We aimed to assess the role of Magnetic Resonance Imaging (MRI) and X-Ray in the evaluation of response to radiosynovectomy (RS) in patients with hemophilic arthropathy. MATERIAL AND METHODS Eleven patients who suffered from hemophilic arthropathy with a mean age of 11.7 (range between 7-15) were included in this study. 148-185 MBq Yttrium 90 silicate (Y-90) was administered intraar...
متن کاملTotal Joint Arthroplasty for Hemophilia
Hemophilia is hereditary x-chromosomal recessive disorders. Hemophilia A is caused by deficiency or absence of coagulation factor VIII and hemophilia B is caused by that of coagu‐ lation factor IX. The prevalence is reported as one in 5000 in the male population and one in 10000 overall. These diseases are classified into three categories according to serum coagula‐ tion factor activity; severe...
متن کاملPrevention of the Musculoskeletal Complications of Hemophilia
Hemophilia is an inherited disorder of clotting factor deficiencies resulting in musculoskeletal bleeding, including hemarthroses, leading to musculoskeletal complications. The articular problems of hemophiliac patients begin in infancy. These include: recurrent hemarthroses, chronic synovitis, flexion deformities, hypertrophy of the growth epiphyses, damage to the articular cartilage, and hemo...
متن کاملOsteoporosis/osteopenia and hemophilic arthropathy in severe hemophilic patients.
BACKGROUND Types A and B hemophilia are coagulation disorders associated with many complications. Osteoporosis is a skeletal condition characterized by the decreased density of normally mineralized bone. This study aims to determine the relationship between osteoporosis and hemophilic arthropathy in severe hemophilia patients over the age of 20 years in Kerman, Iran. METHODS We performed a cr...
متن کاملSubjective results of joint lavage and viscosupplementation in hemophilic arthropathy
OBJECTIVE To assess whether joint lavage, viscosupplementation and triamcinolone improve joint pain, function and quality of life in patients with severe hemophilic arthropathy. METHODS Fourteen patients with knee and/or ankle hemophilic arthritis with and without involvement of other joints underwent joint lavage and subsequent injection of hylan G-F20 and triamcinolone in all affected joint...
متن کامل